Yuan Zhi
Stock Analyst
(n/a)
# 1,580
Out of 4,648 analysts
18
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIR Mirion Technologies | Initiates: Buy | $14 | $14.79 | -5.34% | 1 | Sep 26, 2024 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $4.06 | +343.35% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $7.67 | +95.57% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.87 | +244.63% | 1 | May 15, 2024 | |
| CATX Perspective Therapeutics | Maintains: Buy | $12 → $17 | $12.19 | +39.46% | 2 | Apr 9, 2024 | |
| AZTA Azenta | Maintains: Buy | $61 → $79 | $44.90 | +75.95% | 3 | Feb 1, 2024 | |
| ATNM Actinium Pharmaceuticals | Maintains: Buy | $20 → $16 | $1.76 | +809.09% | 4 | Dec 11, 2023 | |
| TNGX Tango Therapeutics | Initiates: Buy | $16 | $5.16 | +210.08% | 1 | Dec 8, 2023 |
Mirion Technologies
Sep 26, 2024
Initiates: Buy
Price Target: $14
Current: $14.79
Upside: -5.34%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $4.06
Upside: +343.35%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $7.67
Upside: +95.57%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.87
Upside: +244.63%
Perspective Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $12.19
Upside: +39.46%
Azenta
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $44.90
Upside: +75.95%
Actinium Pharmaceuticals
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.76
Upside: +809.09%
Tango Therapeutics
Dec 8, 2023
Initiates: Buy
Price Target: $16
Current: $5.16
Upside: +210.08%